No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use
-
Biopsy, Needle
-
Drug Therapy, Combination
-
Follow-Up Studies
-
Hepatitis C, Chronic / complications
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / pathology
-
Humans
-
Immunohistochemistry
-
Interferon alpha-2
-
Interferon-alpha / adverse effects*
-
Interferon-alpha / therapeutic use
-
Male
-
Middle Aged
-
Polyethylene Glycols / adverse effects*
-
Polyethylene Glycols / therapeutic use
-
Pulmonary Disease, Chronic Obstructive / complications
-
Pulmonary Disease, Chronic Obstructive / diagnosis
-
Pulmonary Disease, Chronic Obstructive / drug therapy
-
Recombinant Proteins
-
Ribavirin / adverse effects
-
Ribavirin / therapeutic use
-
Risk Assessment
-
Sarcoidosis / drug therapy
-
Sarcoidosis / etiology*
-
Sarcoidosis / pathology
-
Skin Diseases / drug therapy
-
Skin Diseases / etiology*
-
Skin Diseases / pathology
-
Steroids / therapeutic use
-
Tattooing / adverse effects*
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Steroids
-
Polyethylene Glycols
-
Ribavirin
-
peginterferon alfa-2a